Q1: How does DNA adductomics offer a better risk assessment compared to standard genotoxicity assays?

A1: Adductomics identifies the molecular cause—the precise chemical binding to the DNA. This direct, structural specificity is vital for confident hazard identification and is the key to moving beyond ambiguous or non-specific toxicity results.

Q2: What is the benefit of your proprietary database in the untargeted screening process?

A2: The database (500+ adducts) and in silico libraries are essential for our untargeted approach because adducts are present at extremely low concentrations.

Q3: Can Creative Biolabs analyze challenging sample types, such as small tissue biopsies or non-invasively collected cells?

A3: Yes. Our workflow is rigorously optimized for complex biological matrices, including fixed tissue, blood, and non-invasively collected oral mucosal cells.

DNA Adductomics & Genotoxic Exposure Assessment Service

Creative Biolabs' service delivers definitive molecular clarity in toxicity assessment, bridging the gap where traditional methods, such as the Ames test or micronucleus assay, often fail. We provide a definitive link between external chemical exposure and internal biological effect, thereby transforming safety testing and risk stratification by revealing the initial molecular event in carcinogenesis. By identifying and quantifying covalent DNA modifications (adducts), we give you actionable data on the biologically effective dose of a genotoxicant, a crucial metric for drug development and regulatory submissions.

Introduction of DNA Adductomics

DNA adductomics is the "omics" discipline that provides the essential link between external chemical exposure and internal biological effect by comprehensively measuring all covalent modifications (adducts) to DNA. Adducts are stable, long-lived biomarkers representing the biologically effective dose of a chemical exposure. Recent peer-reviewed literature confirms that advanced high-resolution mass spectrometry (HRMS) coupled with comprehensive databases is indispensable for identifying these low-level modifications and establishing them as predictive biomarkers across environmental monitoring and preclinical safety assessment.

Specific Deliverables and Predictive Solutions

Comprehensive Molecular Risk Profiling

We move beyond non-specific consequence analysis (like strand breaks) to identify the initiating molecular event of carcinogenesis by quantifying all stable, covalent modifications on the DNA molecule. This provides an indisputable molecular history of genotoxic exposure.

Novel Hazard Identification Through Untargeted Screening

Utilizing our advanced untargeted screening capability, Creative Biolabs can discover previously unknown DNA modifications that may arise from new pharmaceutical impurities, metabolites, or complex environmental contaminants, ensuring you are not limited to screening only for known hazards.

Exposure Risk Stratification

We generate specific, quantifiable adduct biomarkers (e.g., using non-invasive oral cell adducts for smoking risk assessment) that accurately reflect an individual's unique exposure burden, enabling precise research cohort stratification and detailed toxicological investigation.

Preclinical Mechanistic Insight

We quantify drug-DNA adducts, such as the G-NOR-G cross-link confirmed in preclinical models, to directly monitor compound activity and guide structure-activity relationship studies, thereby assessing drug potency at the molecular level in toxicology studies.

If your project requires high-confidence data on the genotoxicity of a compound or a detailed profile of exposure, Request a Detailed Proposal Today.

Detailed Workflow: From Sample to Actionable Biomarker

Our comprehensive, five-stage process ensures accurate identification and quantification of low-level DNA adducts, providing high-quality data suitable for regulatory submission.

Publication

This review presents adductomics as an emerging 'omics' field that studies covalent adducts formed between reactive chemicals and biological molecules like DNA and proteins. It highlights its applications in early disease detection, environmental monitoring, precision medicine, and exposure assessment. While analytical advances have propelled the field, challenges remain in detecting low abundance adducts and standardizing methods. Overall, adductomics is a powerful tool for understanding chemical toxicity and advancing biomedical research and preventive medicine.

Fig.1 Schematic representation of chemical agents forming DNA, RNA, and protein adducts and their subsequent toxicological outcomes. (OA Literature)

Fig.1 Formation and consequences of chemical adducts with DNA, RNA, and proteins. ¹

Why Choose Us?

Creative Biolabs is a recognized leader in adductomics, translating complex molecular data into actionable safety insights for pharmaceutical and environmental studies. Our platform's superiority lies in several unique features: a proprietary database of 500+ adducts for confident untargeted screening; dual adductomics verification (parallel DNA/RNA analysis) for eliminating false positives and identifying true genotoxins; and validated toxicology expertise that delivers quantifiable DNA adducts as predictive biomarkers for risk assessment. Our reports provide a regulatory-ready data structure to support comprehensive environmental risk assessments.

FAQs

Customer Review

Related Services

To ensure a comprehensive and holistic assessment of chemical exposure and biological response, we recommend integrating DNA adductomics with our complementary platforms.

Genotoxicity Assessment Services

Creative Biolabs offers comprehensive services, combining standard regulatory tests with cutting-edge mechanistic/high-throughput methods to detect DNA damage and chromosomal alterations, ensuring reliable compound safety insights.

Learn More →

In Vitro Safety Assessment Services

Creative Biolabs offers in vitro safety assessment services using advanced cell-based assays and high-throughput screening. We provide rapid, reliable, and cost-effective toxicity profiles to accelerate drug development and decision-making.

Learn More →

How to Contact Creative Biolabs

Creative Biolabs offers the highest resolution and specificity in genotoxic exposure assessment. Our service transforms complex molecular data into actionable safety insights, validating your pharmaceutical pipelines, stratifying toxicological risks, and clarifying environmental impacts.

Contact Creative Biolabs today to discuss your project and discover how our genotoxic exposure assessment service can provide the molecular clarity you need.